BORYUNG PHARM financial statements, including revenue, expenses, profit, and loss

The total revenue of 003850 for the last quarter is 233.60 B KRW, and it's 1.02% higher compared to the previous quarter. The net income of Q1 24 is 23.40 B KRW.